Increasingly attention is being given to immune molecules in pancreatic cancer. The
purpose of this study was to understand the potential clinical application of immune …

Abstract Background Immune-related genes (IRGs) are associated with the prognosis of
different cancers and are helpful for the diagnosis and management of systematic treatment …

Background Pancreatic cancer is one of the most common malignant tumors of the digestive
tract, and it has a poor prognosis. Traditional methods are not effective to accurately assess …

Purpose: To identify differentially expressed immune-related genes (DEIRGs) and construct
a model with survival-related DEIRGs for evaluating the prognosis of patients with …

Simple Summary Pancreatic adenocarcinoma (PAAD) is one of the leading causes of
cancer death across the world, with extremely poor clinical outcomes within 5 years. From …

Pancreatic cancer is one of the most lethal malignancies. With the promising prospects
conveyed by immunotherapy in cancers, we aimed to construct an immune‐related gene …

Pancreatic cancer remains to have a high mortality, which is partly due to the lack of effective
treatment strategies. In this study, genes with potential associations with …

Objective Our goal is to construct an immune-related gene prognostic risk index (IRGPRI) for
pancreatic adenocarcinoma (PAAD), and to clarify the immune and molecular features in …

Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Background The immune response in the tumor microenvironment (TME) plays a crucial role
in cancer progression and recurrence. We aimed to develop an immune-related gene (IRG) …